137 related articles for article (PubMed ID: 9840653)
1. Effects of a combined antithrombin III and protein C supplementation in porcine acute endotoxic shock.
Fourrier F; Jourdain M; Tournoys A; Gosset P; Mangalaboyi J; Chopin C
Shock; 1998 Nov; 10(5):364-70. PubMed ID: 9840653
[TBL] [Abstract][Full Text] [Related]
2. Effects of inter-alpha-inhibitor in experimental endotoxic shock and disseminated intravascular coagulation.
Jourdain M; Carrette O; Tournoys A; Fourrier F; Mizon C; Mangalaboyi J; Goudemand J; Mizon J; Chopin C
Am J Respir Crit Care Med; 1997 Dec; 156(6):1825-33. PubMed ID: 9412562
[TBL] [Abstract][Full Text] [Related]
3. Influence of antithrombin III on coagulation and inflammation in porcine septic shock.
Dickneite G; Leithäuser B
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1566-72. PubMed ID: 10364091
[TBL] [Abstract][Full Text] [Related]
4. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies.
Fourrier F; Chopin C; Goudemand J; Hendrycx S; Caron C; Rime A; Marey A; Lestavel P
Chest; 1992 Mar; 101(3):816-23. PubMed ID: 1531791
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
Fourrier F; Chopin C; Huart JJ; Runge I; Caron C; Goudemand J
Chest; 1993 Sep; 104(3):882-8. PubMed ID: 8365305
[TBL] [Abstract][Full Text] [Related]
6. Effects of N omega-nitro-L-arginine methyl ester on the endotoxin-induced disseminated intravascular coagulation in porcine septic shock.
Jourdain M; Tournoys A; Leroy X; Mangalaboyi J; Fourrier F; Goudemand J; Gosselin B; Vallet B; Chopin C
Crit Care Med; 1997 Mar; 25(3):452-9. PubMed ID: 9118662
[TBL] [Abstract][Full Text] [Related]
7. Single Low Dose of Human Recombinant Antithrombin (ATryn) has no Impact on Endotoxin-Induced Disseminated Intravascular Coagulation: An Experimental Randomized Open Label Controlled Study.
Duburcq T; Durand A; Tournoys A; Gnemmi V; Bonner C; Gmyr V; Hubert T; Pattou F; Jourdain M
Shock; 2019 Oct; 52(4):e60-e67. PubMed ID: 30325871
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of antithrombin III, activated protein C and heparin on the inhibition of the tissue thromboplastin-mediated coagulation.
Hirahara K; Etoh Y; Matsuishi T; Suzuki N; Kurata M
Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):692-6. PubMed ID: 2752479
[TBL] [Abstract][Full Text] [Related]
9. The use of antithrombin III (ATIII) for disseminated intravascular coagulation (DIC) during septic shock.
Cohendy R; Lefrant JY; de la Coussaye JE
Intensive Care Med; 1998 Dec; 24(12):1344. PubMed ID: 9885894
[No Abstract] [Full Text] [Related]
10. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia.
Emerson TE; Fournel MA; Redens TB; Taylor FB
Am J Med; 1989 Sep; 87(3B):27S-33S. PubMed ID: 2679067
[TBL] [Abstract][Full Text] [Related]
11. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
Gómez C; Páramo JA; Rocha E
Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
[TBL] [Abstract][Full Text] [Related]
12. A purified antithrombin III--heparin complex as a potent inhibitor of thrombin in porcine endotoxin shock.
Spannagl M; Hoffmann H; Siebeck M; Weipert J; Schwarz HP; Schramm W
Thromb Res; 1991 Jan; 61(1):1-10. PubMed ID: 2020936
[TBL] [Abstract][Full Text] [Related]
13. IMPACT OF OBESITY ON ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION.
Duburcq T; Tournoys A; Gnemmi V; Hubert T; Gmyr V; Pattou F; Jourdain M
Shock; 2015 Oct; 44(4):341-7. PubMed ID: 26125085
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
15. Effects of low molecular weight heparin, alone or combined with antithrombin III, on mortality, fibrin deposits and hemostatic parameters in endotoxin-induced disseminated intravascular coagulation in rabbits.
Hermida J; Montes R; Muñoz MC; Orbe J; Páramo JA; Rocha E
Am J Hematol; 1999 Jan; 60(1):6-11. PubMed ID: 9883799
[TBL] [Abstract][Full Text] [Related]
16. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
17. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
Okajima K
Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
[TBL] [Abstract][Full Text] [Related]
18. Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation.
Kawano S; Uchino S; Endo A; Saito K; Iwai K; Kase Y; Takinami M
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):795-800. PubMed ID: 24806318
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation.
Hauptman JG; Hassouna HI; Bell TG; Penner JA; Emerson TE
Circ Shock; 1988 Jun; 25(2):111-22. PubMed ID: 3390893
[TBL] [Abstract][Full Text] [Related]
20. The initial experience of antithrombin III in the management of neonates with necrotizing enterocolitis.
St Peter SD; Little DC; Calkins CM; Holcomb GW; Snyder CL; Ostlie DJ
J Pediatr Surg; 2007 Apr; 42(4):704-8. PubMed ID: 17448770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
